Drug interaction classified as: metabolism
Source: DDInter
Antidote · Treatment of Opioid-Induced Constipation
Also known as Naldemedine tosylate, Rizmoic
Naldemedine is a peripherally acting opioid receptor antagonist. It decreases the constipating effects of opioids without altering their central analgesic effects. Its principal mechanism for the selective therapeutic effect is peripheral enteric μ-receptor antagonism with minimal CNS penetration.
Manufacturer advises avoid unless potential benefit outweighs risk— animal studies do not indicate toxicity; risk of opioid withdrawal in fetus.
Manufacturer advises avoid—present in milk in animal studies; theoretical risk of opioid withdrawal in breast-fed neonate.
Drug interaction classified as: metabolism
Source: DDInter
Drug interaction classified as: metabolism
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
1 additional low-confidence interaction hidden — those rows lack a documented mechanism or management plan in our sources.
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e, Katzung, BNF·Verified: 2026-05-10 · House clinical team